Outcome of infants with 10 min Apgar scores of 0-1 in a low-resource setting.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 01 06 2021
accepted: 15 10 2021
pubmed: 3 11 2021
medline: 22 6 2022
entrez: 2 11 2021
Statut: ppublish

Résumé

In high-resource settings, postponing the interruption of cardiopulmonary resuscitation from 10 to 20 min after birth has been recently suggested, but data from low-resource settings are lacking. We investigated the outcome of newborns with Apgar scores of 0-1 at 10 min of resuscitative efforts in a low-resource setting. This observational substudy from the NeoSupra trial included all 49 late preterm/full-term newborns with Apgar scores of 0-1 at 10 min of resuscitation. The study was carried out at Mulago National Referral Hospital (Kampala, Uganda) between May 2018 and August 2019. Outcome measures were mortality and hypoxic-ischaemic encephalopathy in the first week of life. All resuscitations were video recorded and daily reviewed by trial researchers. Median duration of resuscitation was 32 min (IQR 17-37). Advanced resuscitation was provided to 21/49 neonates (43%). Overall, 48 neonates (98%) died within 2 days of life (44 in the delivery room, three on the first day and one on the second day) and one survived at 1 week with severe hypoxic-ischaemic encephalopathy. Our study adds information from a low-resource setting to the recent evidence from high-resource settings about prolonging the resuscitation in infants with Apgar scores of 0-1 at 10 min. The vast majority died in the delivery room despite prolonged resuscitative efforts. We confirm that duration of resuscitation should be tailored to the setting, while the focus in low-resource settings should be improving the quality of antenatal and immediately after birth care.

Sections du résumé

BACKGROUND BACKGROUND
In high-resource settings, postponing the interruption of cardiopulmonary resuscitation from 10 to 20 min after birth has been recently suggested, but data from low-resource settings are lacking. We investigated the outcome of newborns with Apgar scores of 0-1 at 10 min of resuscitative efforts in a low-resource setting.
METHODS METHODS
This observational substudy from the NeoSupra trial included all 49 late preterm/full-term newborns with Apgar scores of 0-1 at 10 min of resuscitation. The study was carried out at Mulago National Referral Hospital (Kampala, Uganda) between May 2018 and August 2019. Outcome measures were mortality and hypoxic-ischaemic encephalopathy in the first week of life. All resuscitations were video recorded and daily reviewed by trial researchers.
RESULTS RESULTS
Median duration of resuscitation was 32 min (IQR 17-37). Advanced resuscitation was provided to 21/49 neonates (43%). Overall, 48 neonates (98%) died within 2 days of life (44 in the delivery room, three on the first day and one on the second day) and one survived at 1 week with severe hypoxic-ischaemic encephalopathy.
CONCLUSION CONCLUSIONS
Our study adds information from a low-resource setting to the recent evidence from high-resource settings about prolonging the resuscitation in infants with Apgar scores of 0-1 at 10 min. The vast majority died in the delivery room despite prolonged resuscitative efforts. We confirm that duration of resuscitation should be tailored to the setting, while the focus in low-resource settings should be improving the quality of antenatal and immediately after birth care.

Identifiants

pubmed: 34725104
pii: archdischild-2021-322545
doi: 10.1136/archdischild-2021-322545
doi:

Substances chimiques

Dihydrotachysterol R5LM3H112R

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-424

Investigateurs

Mats Blennow-Bohlin (M)
Tobias Alfvén (T)
Hege Ersdal (H)
Hadija Nalubwama (H)
Allan Mpamize (A)
Damien K Wasswa (DK)
Anita Tumwebaze (A)
Natalia Niombi (N)
Sherinah Nakalembe (S)
Sulphine Twinomuhangi (S)
Dorothy Mugabi (D)

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Thorkild Tylleskär (T)

Centre for International Health, Universitetet i Bergen, Bergen, Norway.

Francesco Cavallin (F)

Independent statistician, Solagna, Italy.

Susanna Myrnerts Höök (SM)

Department of Public Health Sciences, University of Bergen, Bergen, Norway.
Department of Public Health Sciences, Sachs' Children and Youth Hospital, Stockholm, Sweden.

Nicolas J Pejovic (NJ)

Centre for International Health, Universitetet i Bergen, Bergen, Norway.
Department of Neonatology, Sachsska Barnsjukhuset, Stockholm, Sweden.

Clare Lubulwa (C)

Department of Pediatrics and Child Health, Mulago National Referral Hospital, Kampala, Uganda.

Josaphat Byamugisha (J)

Department of Obstetrics and Gynaecology, Mulago National Referral Hospital, Kampala, Uganda.
Department of Obstetrics and Gynaecology, College of Health Sciences, Makerere University, Kampala, Uganda.

Jolly Nankunda (J)

Paediatrics and Child Health, Makerere University, Kampala, Uganda.

Daniele Trevisanuto (D)

Department of Woman's and Child's Health, University of Padova, Padova, Italy daniele.trevisanuto@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH